Immunologic function and survival in hemodialysis patients

Area of Science:

• Nephrology
• Immunology
• Clinical Medicine

Background:

• Medical factors influencing mortality in end-stage renal disease (ESRD) patients on hemodialysis (HD) are known, but the role of immune parameters remains unclear.
• Cytokine metabolism dysregulation is observed in ESRD, yet its association with patient outcomes is not well-established.
• The impact of dialyzer type on survival is noted, but underlying immune mechanisms require elucidation.

Purpose of the Study:

• To investigate the contribution of immunological factors to patient survival in urban hemodialysis patients.
• To test the hypothesis that increased proinflammatory cytokines are associated with increased mortality.
• To determine if improved immune function is associated with enhanced survival in ESRD patients.

Main Methods:

• A prospective, cross-sectional, observational multicenter study involving 230 ESRD patients undergoing hemodialysis.
• Assessment included demographic, anthropometric, and dialysis adequacy (Kt/V, PCR) parameters.
• Immunologic variables measured: circulating cytokines (IL-1, IL-2, IL-4, IL-5, IL-6, IL-12, IL-13, TNF-alpha), CH50, T cell number, and function, analyzed using Cox proportional hazards models.

Main Results:

• Elevated levels of IL-1, TNF-alpha, IL-6, and IL-13 were significantly associated with increased mortality risk.
• Higher levels of IL-2, IL-4, IL-5, IL-12, T-cell number, T-cell function, and CH50 were linked to improved survival.
• Immune parameters were highly intercorrelated, with most cytokine levels exceeding those in normal controls.

Conclusions:

• Increased circulating proinflammatory cytokines are linked to mortality in ESRD patients on HD.
• Improved T-cell function is associated with better survival, independent of other risk factors.
• These immune parameters may serve as valuable outcome markers in ESRD patients.